Table 2.
Variable | Hazard ratio (95% CI) | P |
---|---|---|
Tumour volume | ||
< 0.26 | reference | |
0.26–0.50 | 1.83 (0.45–7.32) | 0.393 |
0.51–1.00 | 1.44 (0.39–5.32) | 0.584 |
1.01–2.00 | 2.61 (0.76–8.97) | 0.127 |
2.01–4.00 | 2.52 (0.74–8.63) | 0.139 |
> 4.00 | 4.3 (1.31–14.09) | 0.016 |
Multivariate PSA, ng/mL | ||
≤□6 | reference | |
6.01–10 | 1.55 (0.90–2.50) | 0.113 |
10.01–20 | 2.06 (1.12–3.77) | 0.020 |
20.01–30 | 4.09 (1.49–11.2) | 0.006 |
> 30 | 6.34 (2.15–18.7) | 0.001 |
Gleason score | ||
2–6 | reference | |
3 + 4 | 2.25 (1.10–4.61) | 0.026 |
4 + 3 | 3.87 (1.70–8.75) | 0.001 |
8–10 | 4.34 (1.89–9.96) | 0.001 |
SVI | 1.92 (1.05–3.50) | 0.034 |
ECE | 2.01 (1.25–3.25) | 0.004 |
SM | 1.61 (1.02–2.55) | 0.042 |
LNI | 0.99 (0.62–1.68) | 0.963 |
Tumour volume, mL | ||
≤ 0.25 | reference | |
0.26–0.50 | 1.26 (0.31–5.18) | 0.748 |
0.51–1.00 | 0.80 (0.21–3.09) | 0.749 |
1.01–2.00 | 1.27 (0.36–4.56) | 0.710 |
2.01–4.00 | 0.79 (0.22–2.87) | 0.721 |
> 4.00 | 1.11 (0.31–3.96) | 0.869 |